Alumis (ALMS) Cash from Financing Activities (2023 - 2025)
Alumis (ALMS) reported Cash from Financing Activities of $1.3 million for Q4 2025, up 26260.0% year-over-year from N/an in Q4 2024, and up 26260.0% quarter-over-quarter from $5000.0 in Q4 2024.
Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash from Financing Activities data on file, last reported at $1.3 million in Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $1.3 million, up 26260.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $236.5 million (down 51.97% YoY), and the FY2025 annual result was $2.1 million, down 99.58% from the prior year.
- Cash from Financing Activities rose to $1.3 million in Q4 2025 per ALMS's latest filing, from $5000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $235.2 million in Q3 2024 and troughed at $5000.0 in Q4 2024.
- A 3-year average of $74.8 million and a median of $29.7 million in 2023 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 500221.28% in 2024 and fell as far as 99.98% in 2024.
- A 3-year view of Cash from Financing Activities shows it stood at $29.7 million in 2023, then slumped by 99.98% to $5000.0 in 2024, then jumped by 26260.0% to $1.3 million in 2025.
- Business Quant data shows ALMS's Cash from Financing Activities at $1.3 million in Q4 2025, $5000.0 in Q4 2024, and $235.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 235.15 Mn |
| Sep 30, 2024 | 235.15 Mn |
| Jun 30, 2024 | 128.06 Mn |
| Jun 30, 2024 | 128.06 Mn |
| Mar 31, 2024 | 129.15 Mn |
| Mar 31, 2024 | 129.15 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Sep 30, 2023 | 47,000.00 |
| Sep 30, 2023 | 47,000.00 |